Haleon plc (HLNCF)
OTCMKTS
· Delayed Price · Currency is USD
4.675
-0.215 (-4.40%)
At close: Dec 5, 2025
Haleon Market Cap
Haleon has a market cap or net worth of $42.79 billion as of December 5, 2025. Its market cap has decreased by -0.18% in one year.
Market Cap
42.79B
Enterprise Value
53.35B
Revenue
15.10B
Ranking
n/a
PE Ratio
20.52
Stock Price
$4.68
Market Cap Chart
Since July 18, 2022, Haleon's market cap has increased from 34.14B to 42.79B, an increase of 25.32%. That is a compound annual growth rate of 6.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 42.79B | 0.04% |
| Dec 31, 2024 | 42.77B | 13.06% |
| Dec 29, 2023 | 37.83B | 3.87% |
| Dec 30, 2022 | 36.42B | 6.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 295.21M |
| Nika Pharmaceuticals | 259.91M |